High glucose protects embryonic cardiac cells against simulated ischemia

Molecular and Cellular Biochemistry

Volumn 284, Issue 1-2, 2006, Pages 87-93

  Malliopoulou, Vassiliki ^a   Xinaris, Christodoulos ^a   Mourouzis, Iordanis ^a   Cokkinos, Alexandros D ^a   Katsilambros, Nikolaos ^c   Pantos, Constantinos ^a   Kardami, Elissavet ^d   Cokkinos, Dennis V ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; IODOACETIC ACID; PROPIDIUM IODIDE; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DEATH; CELL LEVEL; CHEMOLUMINESCENCE; CYTOSOL; EMBRYO; EMBRYO CELL; ENZYME ANALYSIS; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPOXIA; IMMUNOREACTIVITY; NONHUMAN; PROTEIN TRANSPORT; RAT; SIMULATION; STUDENT T TEST; WESTERN BLOTTING; ANIMAL; CELL HYPOXIA; CELL LINE; DRUG EFFECT; METABOLISM; PHOSPHORYLATION;

ANIMALS; CELL HYPOXIA; CELL LINE; GLUCOSE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE C-DELTA; PROTEIN KINASE C-EPSILON; PROTEIN TRANSPORT; RATS;

EID: 33745913020     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-9018-1     Document Type: Article

References (40)

1. Eberli FR, Weinberg EO, Grice WN, Horowitz GL, Apstein CS: Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion in isolated rabbit hearts perfused with erythrocyte suspension. Circ Res. 68: 466-481, 1991
2. Opie LH, Camici PG: Myocardial blood flow, deoxyglucose uptake and myocyte viability in ischemia. J Nucl Med. 33: 1353-1356, 1992
3. Owen P, Dennis S, Opie LH: Glucose flux rate regulates onset of ischemic contracture in globally underperfusedrat heart. Circ Res. 66: 344-354, 1990
4. Mallet RT, Hartman DA, Bunger R: Glucose requirement for postischemic recovery of perfuced working heart. Eur J Biochem. 188: 481-493, 1990
5. Opie LG: Hypothesis: glycolytic rates control cell viability in ischemia. J Appl Cardiol. 3: 407-414, 1998
6. Taegtmeyer H, Goodwin GW, Doenst T, Frazier OH: Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol 80: 3A-10A, 1997
7. Medical Research Council Working Party on the Treatment of Myocardial Infarction: Potassiun, glucose and insulin treatment for acute myocardial infarction. Lancet 2: 1355-1360, 1968
8. Hearse DJ, Stewart DA, Braimbridge MV: Myocardial protection during ischemic cardiac arrest. Possible deleterious effects of glucose and manitol in coronary infusates. J Thorac Cardiovasc Surg 76: 16-23, 1978
9. Neely JR, Grotyohann LW: Role of glycolytic products in damage to ischemic myocardium. Dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts. Circ Res. 55: 816-824, 1984
10. Kersten JR, Schmeling TJ, Orth KG, Pagel PS, Warltier DC: Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol Heart Circ Physiol 275: H721-H725, 1998
11. Opie LH: The glucose hypothesis: Relation to acute myocardial ischaemia. J Mol Cell Cardiol 1: 107-114, 1970
12. Neely JR, Whitmer JT, Roverto MJ: Effects of coronary blood flow on glycolytic flux and intracellular pH in isolated rat hearts. Circ Res 37: 733-741, 1975
13. Hescheler J, Meyer R, Plant S, Krautwurst D, Rosenthal W, Schultz G: Morphological biochemical, and electrophysiological characterization of a clonal cell (H9C2) line from rat heart. Circ Res 69(6): 1476-1486, 1991
14. Inglis AS: Single hydrolysis method for all amino acids, including cysteine and tryptophan. Methods Enzymol 91: 26-36, 1983
15. Bickis IJ, Quastel LH: Effects of metabolic inhibitors on energy metabolism of Ehrlich carcinoma cells. Nature 205(2): 44-46, 1965
16. Herbert JM, Augereau JM, Gleye J, Maffrand JP: Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172(3): 993-999, 1990
17. Chao MD, Chen IS, Cheng JT: Inhibition of protein kinase C translocation from cytosol to membrane by chelerythrine. Planta Med 64(7): 662-663, 1998
18. Farese RV, Konda TS, Davis JA, Standaert M, Pollet RJ, Cooper DR: Insulin rapidly increases diacylglycerol by activating de novo phosphatidic acid synthesis. Science 236: 586-589, 1987
19. Farese RV, Cooper DR, Konda TS, Nair G, Standaert ML, Davis JS, Pollet RJ: Mechanisms whereby insulin increases diacylglycerol in BC3H-1 myocytes. Biochem J 256: 175-184, 1988
20. Draznin B, Leitner JW, Sussman KE, Sherman NA: Insulin and glucose modulate protein kinase C activity in rat adipocytes. Biochem Cell Biol Commun 156: 570-575, 1988
21. Ishizuka T, Hoffman J, Cooper DR, Watson JE, Pushkin DB, Farese RV: Glucose-induced synthesis of diacylglycerol de novo is associated with translocation (activation) of protein kinase C in rat adipocytes. FEBS Lett 249: 234-238, 1989
22. Farese RV, Standaert ML, Arnold RP, Yamada K, Musunuru K, Hernandez H, Mischak H, Cooper DR: Preferential activation of microsomal diacylglycerol/protein kinase C signaling during glucose treatment (De novo phospholipid synthesis) of rat adipocytes. J Clin Invest 93: 1894-1899, 1994
23. Liu G, Cohen M, Mochly-Rosen D, Downey J: Protein kinase C-ε is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol 31: 1937-1948, 1998
24. Ping P, Zhang J, QiuY, Tang X, Manchikalapudi S, CaoX, Bolli R: Ishaemic preconditioning induces selective translocation of protein kinase C isoforms ε and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 81: 404-414, 1997
25. Qiu Y, Ping P, Tang XL, Manchikalapudi S, Rizni A, Zhang J, Takano H, Wu WJ, Teschner S, Bolli R: Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilonis the isoform involved. J Clin Invest 101: 2182-2198, 1998
26. Arnaud C, Jojeux-Faure M, Bottari S, Godin-Ribuot D, Ribuot C: New insight into the signaling pathways of heat stress-induced myocardial preconditioning: Protein kinase Cepsilon translocation and heat shock protein 27 phosphorylation. Clin Exp Pharmacol Physiol. 31(3): 129-133, 2004.
27. Chen CH, Gray MO, Mochly-Rosen D: Cardioprotection from ischemia by a brief exposure to physiological levels of ethanol: Role of epsilon protein kinase C. Proc Natl Acad Sci USA 96: 12784-12789, 1999
28. Dorn GW, Souroujion MC, Liron T, Chen CH, Gray MO, Zhou HZ, Csukai M, Wu Guangyu, Lorenz JN, Mochly-Rosen D: Sustained in vivo cardiac protection by a rationally peptide that causes ε protein kinase C translocation. Proc Natl Acad Sci USA 96: 12798-12803, 1999
29. Cross HR, Murphy E, Bolli R, Ping P, Steenbergen C: Expression of activated PKC epsilon (PKCε) protects the ischaemic heart, without attenuating ischemic H+ production. J Mol Cell Cardiol 2002; 34: 361-367, 2002
30. Fryer R, Wang Y, Hsu A, Gross G: Essential activation of protein kinase C-δ in opioid-initiated cardioprotection. Am J Physiol 280: H1346-1353, 2001
31. Inagaki K, Kihara Y, Hayasida W, Izumi T, Iwanage Y, Yoneda T, Takeuchi, Suyama K, Muso E, Sasayama: Circulation 101: 797-804, 2000
32. Fryer LGD, Holness MJ, Decock JB, Sugden MC: Cardiac protein kinase C expression in two models of cardiac hypertrophy associated with an activated cardiac rennin-angiotensin system: Effect of experimental hyperthyroidism and genetic hypertension (the mREN-2 rat). J Endocr 158: 27-33, 1998
33. Pantos C, Malliopoulou V, Mourouzis I, Karamanoli E, Paizis I, Steimberg N, Varonos D, Cokkinos DV: Long-term thyroxine administration protects the heart in a similar pattern as ischaemic preconditioning. Thyroid 12: 325-329, 2002
34. Zhao J, Renner O, Wightman L, Sugden P, Stewart L, Latchman D, Marber MS: The expression of constitutively active isotypes of protein kinase C to investigate preconditioning. J Biol Chem 273: 23072-23079, 1998
35. Chen L, Hahn H, Wu E, Chen CH, Liron T, Schectman D, Cavallaro G, Banci L, Guo Y, Bolli R, Dorn GW 2nd, Mochly-Rosen D: Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci U S A. 2001 Sep 25; 98(20): 11114-11119
36. Schaffer W, Croft CB, Solodushko V: Cardioprotective effect of chronic hyperglycemia: Effect on hypoxia-induced apoptosis and necrosis. Am J Physiol Heart Circ Physiol. 2000 Jun; 278(6): H1948-H1954
37. Pastukh V, Wu S, Ricci C, Mozaffari M, Schaffer S: Reversal of hyperglycemic preconditioning by angiotensin II: Role of calcium transport. Am J Physiol Heart Circ Physiol. 2005 Apr; 288(4): H1965-H1975
38. Santalucia T, Camps M, Castello A, Munoz P, Nuel A, Testar X, Palacin M, Zorzano A: Developmental regulation of GLUT-1 (erythroid/Hep G2) and GLUT-4 (muscle/fat) glucose transporter expression in rat heart, skeletal muscle, and brown adipose tissue. Endocrinology. 1992 Feb;130(2): 837-846
39. Bandyopadhyay G, Sajan MP, Kanoh Y, Standaert ML, Burke TR, Quon MJ, Reed BC, Dikic I, Noel LE, Newgard CB, Farese R: Glucose activates mitogen-activated protein kinase (extracellular signal-regulated kinase) through proline-rich tyrosine kinase-2 and the glut1 glucose transporter. J Biol Chem 275(52): 40817-40826, 2000
40. Baines CP, Molkentin JD: Stress signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol 38: 47-62, 2005